1. The enhanced immunopharmacology of VIB4920, a novel Tn3 fusion protein and CD40L antagonist, and assessment of its safety profile in cynomolgus monkeys. (3rd February 2020) Authors: Nicholson, Simone M.; Casey, Kerry A.; Gunsior, Michele; Drabic, Stacey; Iverson, William; Cook, Halie; Scott, Stephen; O'Day, Terry; Karanth, Subramanya; Dixit, Rakesh; Ryan, Patricia C. Journal: British journal of pharmacology Issue: Volume 177:Number 5(2020) Page Start: 1061 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗